ProfileGDS5822 / ILMN_2713872
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 95% 95% 93% 96% 93% 95% 95% 94% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11113.495
GSM1276600PDAC Late Ablation Control 21052.795
GSM1276601PDAC Late Ablation Control 3989.693
GSM1276602PDAC Late Ablation 11360.396
GSM1276603PDAC Late Ablation 2848.493
GSM1276604PDAC Late Ablation 31263.695
GSM1303940PDAC Late Ablation_anti-CTLA4 11124.895
GSM1303941PDAC Late Ablation_anti-CTLA4 21161.494
GSM1303942PDAC Late Ablation_anti-CTLA4 31085.894